SH3BP5-AS1: A Potential Drug Target and Biomarker (G100505696)

Target Name: SH3BP5-AS1

NCBI ID: G100505696

SH3BP5-AS1

Other Name(s): SH3BP5 antisense RNA 1

SH3BP5-AS1: A Potential Drug Target and Biomarker

SH3BP5-AS1, also known as SH3BP5, is a protein that is expressed in various tissues, including brain, heart, and skeletal muscles. It is a member of the S1P family, which is a well-known signaling pathway that plays a crucial role in various cellular processes, including cell signaling, inflammation, and stress responses.

Recent studies have identified SH3BP5-AS1 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This is due to its unique structure, function, and regulation, as well as its involvement in multiple cellular processes that are associated with the development and progression of these diseases.

Potential Drug Targets

SH3BP5-AS1 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its unique structure and function make it an attractive target for small molecules, antibodies, and other therapeutic agents.

In cancer, SH3BP5-AS1 has been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is known to play a crucial role in the development and progression of cancer, and inhibition of TGF-β signaling has been shown to be effective in treating various types of cancer.

In neurodegenerative diseases, SH3BP5-AS1 has been linked to the development and progression of neurodegeneration. Its involvement in the regulation of cellular processes that are associated with neurodegeneration makes it a potential target for therapeutic agents that can slow the progression of these diseases.

In cardiovascular diseases, SH3BP5-AS1 has been shown to be involved in the regulation of cell signaling pathways that are associated with cardiovascular disease. This includes the regulation of angiogenesis, inflammation, and cellular signaling pathways that are associated with the development and progression of cardiovascular disease.

Biomarkers

SH3BP5-AS1 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its unique structure and function make it an attractive target for diagnostic agents that can detect and monitor the presence of this protein in various tissues and fluids.

In cancer, SH3BP5-AS1 has been shown to be expressed in various types of cancer, including breast, ovarian, and colorectal cancers. Its expression has been shown to be associated with the development and progression of these cancers, and may be a useful biomarker for the diagnosis and prognosis of these diseases.

In neurodegenerative diseases, SH3BP5-AS1 has been detected in various types of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its presence suggests that it may be a useful biomarker for the diagnosis and prognosis of these diseases.

In cardiovascular diseases, SH3BP5-AS1 has been detected in various types of cardiovascular diseases, including heart failure, hypertension, and stroke. Its presence suggests that it may be a useful biomarker for the diagnosis and prognosis of these diseases.

Conclusion

In conclusion, SH3BP5-AS1 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its unique structure and function make it an attractive target for small molecules, antibodies, and other therapeutic agents. Further research is needed to fully understand its role in these diseases and to develop effective diagnostic and therapeutic agents.

Protein Name: SH3BP5 Antisense RNA 1

The "SH3BP5-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SH3BP5-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets